Copyright © Philip M. Parker, INSEAD. Terms of Use.
| Domain | Definition |
Health | Antibodies, often monoclonal, in which the two antigen-binding sites are specific for separate antigenic determinants. They are artificial antibodies produced by chemical crosslinking, fusion of hybridoma cells, or by molecular genetic techniques. They function as the main mediators of targeted cellular cytotoxicity and have been shown to be efficient in the targeting of drugs, toxins, radiolabeled haptens, and effector cells to diseased tissue, primarily tumors. (references) |
Source: compiled by the editor from various references; see credits. | |
Hexadecimal (or equivalents, 770AD-1900s) (references)41 4E 54 49 42 4F 44 49 45 53 2C 42 49 53 50 45 43 49 46 49 43 |
| Leonardo da Vinci (1452-1519; backwards) (references)
|
Binary Code (1918-1938, probably earlier) (references)01000001 01001110 01010100 01001001 01000010 01001111 01000100 01001001 01000101 01010011 00101100 00100000 01000010 01001001 01010011 01010000 01000101 01000011 01001001 01000110 01001001 01000011 |
HTML Code (1990) (references)A N T I B O D I E S ,   B I S P E C I F I C |
ISO 10646 (1991-1993) (references)0041 004E 0054 0049 0042 004F 0044 0049 0045 0053 002C 0042 0049 0053 0050 0045 0043 0049 0046 0049 0043 |
Encryption (beginner's substitution cypher): (references)3548544336493843395314236435350393743404337 |
| 1. Orthography 2. Bibliography |
Copyright © Philip M. Parker, INSEAD. Terms of Use.
